Drug intelligence / Profile preview

norethisterone

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Ethistron is a pharmaceutical product developed and marketed by Rowez Life Sciences, containing the active ingredient norethisterone (also known as norethindrone). Norethisterone is a potent, synthetic progestin belonging to the 19-nortestosterone family. It functions primarily as an agonist at the progesterone receptor, mimicking the physiological effects of endogenous progesterone. By activating these receptors in the hypothalamus and pituitary gland, it inhibits the secretion of gonadotropins, thereby preventing ovulation. In the uterus, it transforms a proliferative endometrium into a secretory one and, at higher doses, can treat endometriosis by inducing decidualization and subsequent atrophy of endometrial tissue. Ethistron is typically indicated for the management of various gynecological conditions, including abnormal uterine bleeding, primary and secondary amenorrhea, and endometriosis.

Brand names
Ethistron
Other names
Norethindrone17alpha-ethynyl-19-nortestosterone
02

Targets

PR (Progesterone receptor)ESR1 (ERα)GR (Glucocorticoid receptor)PGRMC1ESR2 (ERβ)AR (Adrenergic receptors)

Beyond the preview

Go deeper on norethisterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on norethisterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call